查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1698050

DNA 修復藥物市場 - 全球產業規模、佔有率、趨勢、機會與預測，按藥物類型、應用、配銷通路、地區和競爭細分，2020-2030F

DNA Repair Drugs Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Drug Type, By Application, By Distribution Channel, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球 DNA 修復藥物市場價值為 78.5 億美元，預計在預測期內將實現強勁成長，到 2030 年的複合年成長率為 12.85%。全球 DNA 修復藥物市場是製藥和醫療保健產業中一個充滿活力且快速發展的領域。 DNA修復藥物是一類專門用於針對和糾正細胞DNA異常的藥物。這些藥物在遺傳疾病和各種癌症的治療中發揮關鍵作用，其中 DNA 損傷和突變是疾病進展的主要促進因素。本市場概覽深入分析了影響全球 DNA 修復藥物市場格局的關鍵因素、趨勢、挑戰和機會。

市場概覽
預測期 2026-2030
2024 年市場規模 78.5 億美元
2030年市場規模 162.5億美元
2025-2030 年複合年成長率 12.85%
成長最快的領域 腫瘤學
最大的市場 北美洲

主要市場促進因素

癌症發生率上升

主要市場挑戰

DNA修復機制的複雜性

主要市場趨勢

精準醫療與個人化治療

目錄

第 1 章：產品概述

第2章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第5章：全球DNA修復藥物市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依藥物類型（烷化劑、PARP抑制劑、拓樸異構酶抑制劑、其他）
    • 依應用（神經退化性疾病、腫瘤、心血管疾病、中風）
    • 按配銷通路（零售藥局、醫院藥局、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美DNA修復藥物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 加拿大
    • 墨西哥

第7章：歐洲DNA修復藥物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太地區DNA修復藥物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲DNA修復藥物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲DNA修復藥物市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 合併與收購

第13章：全球 DNA 修復藥物市場：SWOT 分析

第 14 章：競爭格局

  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd.
  • Abbvie Inc.
  • Pfizer Inc.
  • Astrazeneca plc
  • Sanofi SA
  • Bayer AG
  • Gilead Sciences Inc.
  • Merck & Co. Inc.
  • Novartis AG

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 17252

Global DNA Repair Drugs Market was valued at USD 7.85 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 12.85% through 2030. The Global DNA Repair Drugs Market is a dynamic and rapidly evolving segment of the pharmaceutical and healthcare industry. DNA repair drugs are a specialized category of medications designed to target and correct abnormalities in the DNA of cells. These drugs play a critical role in the treatment of genetic diseases and various forms of cancer, where DNA damage and mutations are key drivers of disease progression. This market overview provides insights into the key factors, trends, challenges, and opportunities shaping the landscape of the Global DNA Repair Drugs Market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 7.85 Billion
Market Size 2030USD 16.25 Billion
CAGR 2025-203012.85%
Fastest Growing SegmentOncological
Largest MarketNorth America

Key Market Drivers

Increasing Cancer Incidence

The global population is aging, and this demographic shift has a significant impact on cancer incidence. Cancer can occur at any age; however, its prevalence increases significantly with aging. In 2022, approximately 53% of diagnosed cancer cases were in individuals aged 65 and above, highlighting the strong correlation between aging populations and rising cancer incidence. With increasing age, individuals are more susceptible to genetic mutations that can lead to cancer. As the elderly population grows, so does the prevalence of cancer, creating a substantial demand for innovative treatments like DNA repair drugs. Modern lifestyles often involve exposure to numerous cancer risk factors, including poor dietary habits, sedentary lifestyles, and increased consumption of tobacco and alcohol. Research indicates that 90-95% of cancer cases can be attributed to environmental and lifestyle factors, emphasizing a significant preventable risk component. These lifestyle choices contribute to the rise in cancer cases. DNA repair drugs are seen as potential solutions to address the genetic damage caused by such risk factors.

Key Market Challenges

Complexity of DNA Repair Mechanisms

One of the primary challenges in the development of DNA repair drugs is the intricate nature of DNA repair mechanisms. DNA repair is a highly regulated and multifaceted process involving various enzymes, pathways, and checkpoints. Different types of DNA damage require specific repair mechanisms. Designing drugs that can effectively target and modulate these complex processes while minimizing off-target effects is a formidable task. Additionally, DNA repair mechanisms vary between individuals, making it challenging to create a one-size-fits-all solution. Personalized medicine approaches require tailoring treatments to an individual's genetic profile, further complicating drug development and clinical trials.

Key Market Trends

Precision Medicine and Personalized Treatment

One of the most significant trends in the DNA Repair Drugs Market is the shift towards precision medicine. Advances in genomics and molecular diagnostics have enabled healthcare providers to tailor treatment plans to an individual's genetic profile. This trend recognizes that each patient's genetic makeup is unique, influencing their response to DNA repair drugs and other therapies. By identifying specific genetic mutations and DNA repair deficiencies in patients, healthcare professionals can select the most appropriate DNA repair drugs or combination therapies. This approach maximizes treatment efficacy while minimizing side effects, representing a paradigm shift in healthcare towards personalized, patient-centric treatments.

Key Market Players

  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd.
  • Abbvie Inc.
  • Pfizer Inc.
  • Astrazeneca plc
  • Sanofi S.A.
  • Bayer AG
  • Gilead Sciences Inc.
  • Merck & Co. Inc.
  • Novartis AG

Report Scope:

In this report, the Global DNA Repair Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

DNA Repair Drugs Market, By Drug Type:

  • Alkylating Agents
  • PARP Inhibitors
  • Topoisomerase Inhibitors
  • Other

DNA Repair Drugs Market, By Application:

  • Neurodegenerative Diseases
  • Oncological
  • Cardiovascular Diseases
  • Stroke

DNA Repair Drugs Market, By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

DNA Repair Drugs Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global DNA Repair Drugs Market.

Available Customizations:

Global DNA Repair Drugs market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global DNA Repair Drugs Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Drug Type (Alkylating Agents, PARP Inhibitors, Topoisomerase Inhibitors, Other)
    • 5.2.2. By Application (Neurodegenerative Diseases, Oncological, Cardiovascular Diseases, Stroke)
    • 5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America DNA Repair Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Drug Type
    • 6.2.2. By Application
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States DNA Repair Drugs Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Drug Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada DNA Repair Drugs Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Drug Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico DNA Repair Drugs Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Drug Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Distribution Channel

7. Europe DNA Repair Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Drug Type
    • 7.2.2. By Application
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany DNA Repair Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Drug Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. United Kingdom DNA Repair Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Drug Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Italy DNA Repair Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Drug Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. France DNA Repair Drugs Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Drug Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain DNA Repair Drugs Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Drug Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific DNA Repair Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Drug Type
    • 8.2.2. By Application
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China DNA Repair Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Drug Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India DNA Repair Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Drug Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan DNA Repair Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Drug Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea DNA Repair Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Drug Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia DNA Repair Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Drug Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Distribution Channel

9. South America DNA Repair Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Drug Type
    • 9.2.2. By Application
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil DNA Repair Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Drug Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Argentina DNA Repair Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Drug Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Colombia DNA Repair Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Drug Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa DNA Repair Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Drug Type
    • 10.2.2. By Application
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa DNA Repair Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Drug Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia DNA Repair Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Drug Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. UAE DNA Repair Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Drug Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global DNA Repair Drugs Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. GlaxoSmithKline plc
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. F. Hoffmann-La Roche Ltd.
  • 14.3. Abbvie Inc.
  • 14.4. Pfizer Inc.
  • 14.5. Astrazeneca plc
  • 14.6. Sanofi S.A.
  • 14.7. Bayer AG
  • 14.8. Gilead Sciences Inc.
  • 14.9. Merck & Co. Inc.
  • 14.10.Novartis AG

15. Strategic Recommendations

16. About Us & Disclaimer